Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation
Clinical trial NCT02125071 · COMPLETED
Trial details
- NCT number
- NCT02125071
- Sponsor
- Dong-Gu Kim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.